|1.||Wilson, William R: 6 articles (09/2015 - 04/2003)|
|2.||Laskin, Jeffrey D: 5 articles (12/2015 - 01/2011)|
|3.||Laskin, Debra L: 5 articles (12/2015 - 01/2011)|
|4.||Agarwal, Rajesh: 5 articles (05/2015 - 10/2012)|
|5.||Tewari-Singh, Neera: 5 articles (05/2015 - 10/2012)|
|6.||Inturi, Swetha: 5 articles (05/2015 - 10/2012)|
|7.||Jain, Anil K: 5 articles (05/2015 - 10/2012)|
|8.||Duvic, Madeleine: 5 articles (01/2015 - 03/2003)|
|9.||Malaviya, Rama: 4 articles (12/2015 - 12/2012)|
|10.||Gow, Andrew J: 4 articles (12/2015 - 01/2011)|
|1.||Hodgkin Disease (Hodgkin's Disease)
10/01/1970 - "Long-term remission in Hodgkin's disease after nitrogen mustard therapy."
11/01/1959 - "[Clinical studies on nitrogen mustard and roentgen therapy of Hodgkin's disease]."
05/01/1998 - "[Hodgkin's disease in two children of mother treated with nitrogranulogen]."
12/01/1992 - "Four patients with fresh Hodgkin's disease were treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride (NH2-O). "
12/01/1992 - "[Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride]."
03/24/1955 - "The palliation and remission of cancer with combined corticosteroid and nitrogen mustard therapy; a report of 100 cases."
09/01/1979 - "Combined nitrogen mustard--radiation studies with a mouse tumor."
11/01/1965 - "A study on immunological therapy for cancer by using nitrogen mustard-treated cancer tissue."
01/01/1964 - "[STUDIES ON THE EFFECT OF NEW NITROGEN MUSTARD ANALOGES ON NK/LY TRANSPLANTABLE TUMORS]."
06/01/1961 - "Studies on the metabolism of ratascites-tumors with nitrogen mustard sensitive and resistant strains. "
01/01/2013 - "The use of a novel mechlorethamine, 0.02%, gel in the treatment of patients with mycosis fungoides is effective and safe. "
03/15/1999 - "To compare the efficacy of total skin electron beam therapy (TSEBT) with or without adjuvant topical nitrogen mustard (+/- HN2) with topical nitrogen mustard (HN2) alone as initial management of T2 and T3 mycosis fungoides (MF). "
01/01/1983 - "Remission of lesions in mycosis fungoides following topical application of nitrogen mustard. "
07/01/1980 - "In 10 patients with mycosis fungoides (MF) who were in clinical remission following local treatment with nitrogen mustard, cell-mediated immunity was investigated by means of tests for lymphocytes, forming rosettes in the peripheral blood, and the graft-vs-host reaction as well as intradermal skin tests. "
12/01/1968 - "In the present study, topically applied nitrogen mustard solution was used to control recurrences of mycosis fungoides following electron beam therapy in 11 patients. "
11/01/2002 - "Mechlorethamine is frequently used in the treatment of cutaneous lymphoma, but its application is limited in 30-80% of cases because of cutaneous intolerance. "
05/01/1997 - "A 21-year-old woman with malignant lymphoma received a large dose of nitrogen mustard followed by autologous bone marrow. "
01/01/1958 - "Antitumor effects of homologous immune serum, immune lymphocytes and nitrogen mustard against a rat lymphoma."
11/14/1953 - "[Nitrogen mustard gas therapy of tuberculous lymphoma]."
06/01/1953 - "The use of nitrogen mustard in the management of two pregnant lymphoma patients."
05/01/1951 - "[Therapeutic efficacy of nitrogen mustard in a case of chronic lymphatic leukemia with diffuse cutaneous leukemia]."
01/01/2006 - "Therapeutic targets in the nitrogen mustard sensitivity of B-cell chronic lymphocyte leukemia (B-CLL)."
05/01/1994 - "The cumulative dose of mechlorethamine was the most important factor in determining leukemia risk. "
01/01/1989 - "The 10-year cumulative incidence of leukemia was zero in patients treated with limited RT alone, 2.4% in those treated with extended RT alone, 0% in those treated with a combination of RT and CT without nitrogen mustard, and 12.4% in those treated with RT + nitrogen mustard. "
01/01/1989 - "A dose response was observed, with the risk relative to general population incidence rates being 45 in patients having been treated with 1-59 mg (total dose) of nitrogen mustard, 211 in those treated with 60-119 mg, and 636 in those treated with greater than or equal to 120 mg. No other factors were found to be associated with leukemia risk. "
|6.||Vinblastine (Vinblastine Sulfate)
|1.||Drug Therapy (Chemotherapy)
|3.||Combination Drug Therapy (Combination Chemotherapy)
|4.||Bone Marrow Transplantation (Transplantation, Bone Marrow)